Redcare Pharmacy NV

Informe acción XTRA:RDC

Capitalización de mercado: €2.4b

Redcare Pharmacy Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Redcare Pharmacy de 48.9% y 17% por año respectivamente. Se prevé que el BPA crezca en un 1% al año. Se espera que la rentabilidad financiera sea de 13.7% en 3 años.

Información clave

47.4%

Tasa de crecimiento de los beneficios

0.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Consumer Retailing10.7%
Tasa de crecimiento de los ingresos17.0%
Rentabilidad financiera futura12.9%
Cobertura de analistas

Good

Última actualización26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Apr 21
Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Apr 07
Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Mar 25
Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Feb 13
Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Dec 24
Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Dec 06
Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Sep 07
Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Aug 02
Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Jul 17
Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

May 28
Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

May 11
Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

We Think Shop Apotheke Europe (ETR:SAE) Has A Fair Chunk Of Debt

Jan 10
We Think Shop Apotheke Europe (ETR:SAE) Has A Fair Chunk Of Debt

Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Sep 25
Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Is Shop Apotheke Europe (ETR:SAE) Weighed On By Its Debt Load?

Jun 08
Is Shop Apotheke Europe (ETR:SAE) Weighed On By Its Debt Load?

Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Feb 28
Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Here's Why Shop Apotheke Europe (ETR:SAE) Has A Meaningful Debt Burden

Aug 01
Here's Why Shop Apotheke Europe (ETR:SAE) Has A Meaningful Debt Burden

Shop Apotheke Europe N.V.'s (ETR:SAE) About To Shift From Loss To Profit

May 11
Shop Apotheke Europe N.V.'s (ETR:SAE) About To Shift From Loss To Profit

Shop Apotheke Europe (ETR:SAE) Has A Somewhat Strained Balance Sheet

Apr 14
Shop Apotheke Europe (ETR:SAE) Has A Somewhat Strained Balance Sheet

Insider Buying: The Shop Apotheke Europe N.V. (ETR:SAE) Chairman of the Managing Board & CEO Just Bought €96k Worth Of Shares

Mar 14
Insider Buying: The Shop Apotheke Europe N.V. (ETR:SAE) Chairman of the Managing Board & CEO Just Bought €96k Worth Of Shares

The Shop Apotheke Europe (ETR:SAE) Share Price Is Up 399% And Shareholders Are Delighted

Feb 24
The Shop Apotheke Europe (ETR:SAE) Share Price Is Up 399% And Shareholders Are Delighted

Previsiones de crecimiento de beneficios e ingresos

XTRA:RDC - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20263,527627112910
12/31/20252,90546228810
12/31/20242,379-7-345810
3/31/20241,987-10038N/A
12/31/20231,799-122361N/A
9/30/20231,595-16-240N/A
6/30/20231,404-45-1333N/A
3/31/20231,272-65-59-9N/A
12/31/20221,204-78-83-29N/A
9/30/20221,165-110-68-16N/A
6/30/20221,118-105-481N/A
3/31/20221,081-91-406N/A
12/31/20211,060-74-3212N/A
9/30/20211,037-39-1435N/A
6/30/20211,038-29-2827N/A
3/31/20211,020-18-1735N/A
12/31/2020968-17-3618N/A
9/30/2020895-15-56-19N/A
6/30/2020827-20-43-19N/A
3/31/2020758-27-38-16N/A
12/31/2019701-36-45-31N/A
9/30/2019660-41-25-11N/A
6/30/2019621-40-22-10N/A
3/31/2019584-40-39-26N/A
12/31/2018540-34-26-15N/A
9/30/2018481-31-40-31N/A
6/30/2018415-28-38-24N/A
3/31/2018351-24-23-17N/A
12/31/2017284-21N/A-23N/A
9/30/2017244-22N/A-11N/A
6/30/2017222-20N/A-16N/A
3/31/2017200-20N/A-14N/A
12/31/2016177-18N/A-17N/A
9/30/2016159-13N/A-5N/A
6/30/2016147-13N/A-5N/A
3/31/2016136-12N/A-7N/A
12/31/2015126-11N/A-9N/A
12/31/201485-5N/A-4N/A
12/31/201355-3N/A-4N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que RDC sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (0.6%).

Beneficios vs. Mercado: Se prevé que RDC sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que RDC sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (17.5% al año) de RDC crezcan más rápidamente que los del mercado German (5.4% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 17.5% al año) de RDC crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de RDC sea baja dentro de 3 años (13.7%).


Descubre empresas en crecimiento